ALBERTDAVD vs VALIANTLAB: Stock Comparison

Albert David Limited vs Valiant Laboratories Limited

Live data: 22 July 2026, 2:53 PM IST • Source: NSE and company filings

Albert David Limited is the larger company by market capitalisation. Albert David Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Albert David Limited and Valiant Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ALBERTDAVD is more favourable on 9 of 13 scored metrics and VALIANTLAB on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ALBERTDAVD is the larger company
₹391 Cr vs ₹332 Cr
P/E Ratio
ALBERTDAVD has a lower P/E
-264.18x vs -101.88x
P/B Ratio
ALBERTDAVD has a lower P/B
1.01x vs 1.07x
EPS
VALIANTLAB has higher earnings per share
₹-0.05 vs ₹-2.65
Dividend Yield
ALBERTDAVD has a higher dividend yield
0.72% vs 0%
Revenue Growth (TTM YoY)
ALBERTDAVD has faster revenue growth
14.6% vs 0%
Qtr Sales Growth
VALIANTLAB has stronger quarterly sales growth
148% vs 14.6%
Qtr Profit Growth
VALIANTLAB has stronger quarterly profit growth
457% vs -107%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALBERTDAVDVALIANTLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALBERTDAVDVALIANTLAB
Live Price₹689.85₹81.65
Day Change-0.93%2.55%
Volume1,44087,489
52-Week High₹922.95₹100.98
52-Week Low₹579.9₹49.51
Distance from 52W High-25.26%-19.14%

Valuation

MetricALBERTDAVDVALIANTLAB
Market Cap₹391 Cr₹332 Cr
P/E Ratio-264.18x-101.88x
P/B Ratio1.01x1.07x
EPS₹-2.65₹-0.05
Book Value₹686.04₹50.08
Dividend Yield0.72%0%

Growth

MetricALBERTDAVDVALIANTLAB
Revenue Growth (TTM YoY)14.6%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth14.6%148%
Qtr Profit Growth-107%457%

Profitability & Leverage

MetricALBERTDAVDVALIANTLAB
ROE-0.38%-1.05%
ROCE0.77%-0.95%
Net Margin-0.45%-1.38%
Operating Margin1.64%1.12%
Debt to Equity0.08x0.14x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricALBERTDAVDVALIANTLAB
Promoter Holding62.24%74.94%
FII Holding0.58% 0.02 pp0% 0.2 pp
DII Holding1.66%0%
Public Holding35.52% 0.02 pp25.06% 0.2 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Albert David Limited and Valiant Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.